Insulet Q3 2026: EPS Beats by 25%, Buyback and Raised Guidance
As seen on the 24/7 Wall St. homepage on November 4, 2026.
International Omnipod sales jumped 31.7%, enough for Insulet to lift full-year constant-currency revenue growth guidance and double its margin expansion target. The board also approved a buyback, with part of it planned for the fourth quarter.
Continue ReadingShow less
Insulet reported adjusted earnings per share of $1.99 for the third quarter of 2026, clearing the consensus estimate of $1.59 by 25.35%. Revenue of $842 million came in just above the $832.6 million estimate, growing 19.2% year over year, with margin expansion contributing alongside top-line growth.
The standout driver was International Omnipod, which grew 31.7%, pushing total constant-currency revenue growth above the high end of management's prior guidance range. Adjusted EBITDA reached 27.7% of revenue, while adjusted operating margin widened 490 basis points year over year. GAAP diluted EPS came in at $2.03, helped in part by a net favorable warranty adjustment tied to voluntary medical device corrections issued earlier in the year.
On the strength of those results, Insulet raised its full-year International Omnipod growth outlook to 32% to 33% in constant currency, up from 30% to 32%. The adjusted operating margin expansion target was doubled, moving from roughly 100 basis points to roughly 150 basis points year over year. Full-year adjusted EPS growth guidance of more than 30% was left unchanged.
Sponsored
The board approved a $1 billion share repurchase program, with approximately $400 million of that expected to be deployed in the fourth quarter, funded with existing cash. CEO Ashley McEvoy stated: "The share repurchase we are announcing today demonstrates our confidence in the strength of the Omnipod platform and Insulet's long-term trajectory." Cash and equivalents stood at $584.4 million on the balance sheet, a figure investors will weigh against the scale of the planned Q4 buyback.
Reported results and the size of the beats have trended higher since Q4 2024, with no quarter in that stretch missing the consensus estimate. That consistency, combined with a raised guidance floor and a large capital return announcement, sets a high bar for the fourth quarter.
Mentioned: PODD